Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

Levothyroxine BE [Design Issues]

posted by pjs – India, 2015-07-29 13:32 (3630 d 16:10 ago) – Posting: # 15166
Views: 7,227

Dear all,

We are preparing three strengths of the Levothyroxin sodium oral solution 25 mcg/5ml, 50 mcg/5ml and 100 mcg/5ml for EMA submission.

Any one could provide some reference for the pharmacokinetic linearity of the same.

Also is levothyroxine considered as a NTI?

RMS is UK.

Thanks.
Regards,
PJS

Complete thread:

Levothyroxine formulations drcampos 2007-04-24 04:46 [Design Issues]
- Levothyroxine BE drcampos 2007-07-19 21:56
  - Levothyroxine BEpjs 2015-07-29 11:32
    - BE of a solution, NTID or not… Helmut 2015-07-29 12:43
      - BE of a solution, NTID or not… pjs 2015-07-29 13:05

Admin contact
23,427 posts in 4,929 threads, 1,680 registered users;
34 visitors (0 registered, 34 guests [including 11 identified bots]).
Forum time: 05:42 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other. Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz